Prot #JCAR017-BCM-003: A Global Randomized Multicenter Phase 3 Trial to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects with High-Risk, Transplant-Eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas (TR

Project: Research project

StatusActive
Effective start/end date10/21/1910/21/22

Funding

  • ICON Clinical Research, LLC (Prot #JCAR017-BCM-003)
  • Celgene Corporation (Prot #JCAR017-BCM-003)